Carmat Overview
- Status
-
Private
- Employees
-
182
- Latest Deal Type
-
Buyout/LBO
- (Cancelled)
- Financing Rounds
-
24
Carmat General Information
Description
Carmat is a France-based company dedicated to designing, manufacturing, and marketing Aeson, the artificial heart. The company's mission is to establish Aeson as the primary alternative to heart transplantation, offering a life-saving therapeutic option for patients with end-stage biventricular heart failure who face a severe shortage of donor hearts.
Contact Information
Website
carmat-phrt.comCorporate Office
- 36, avenue de Europe Immeuble
- Etendard
- 78140 Vélizy Villacoublay
- France
Corporate Office
- 36, avenue de Europe Immeuble
- Etendard
- 78140 Vélizy Villacoublay
- France
Carmat Timeline
Carmat Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Carmat Comparisons
Industry
Financing
Details
Carmat Competitors (12)
One of Carmat’s 12 competitors is SynCardia Systems, a Formerly PE-Backed company based in Tucson, AZ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SynCardia Systems | Formerly PE-Backed | Tucson, AZ | ||||
| Valcare Medical | Venture Capital-Backed | Herzliya, Israel | ||||
| JenaValve Technology | Private Equity-Backed | Irvine, CA | ||||
| BrioHealth Solutions | Venture Capital-Backed | Suzhou, China | ||||
| enVVeno Medical | Formerly PE-Backed | Irvine, CA |
Carmat Patents
Carmat Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4403137-A1 | System for attaching a heart valve to a cardiac prosthesis and cardiac prosthesis provided with such an attachment system. | Pending | 17-Jan-2023 | ||
| US-20260216491-A1 | System for attaching a heart valve to a heart prosthesis and heart prosthesis provided with an attachment system of this kind | Pending | 17-Jan-2023 | ||
| WO-2024153355-A1 | System for attaching a heart valve to a heart prosthesis and heart prosthesis provided with an attachment system of this kind | Inactive | 17-Jan-2023 | ||
| FR-3144913-B1 | System for fixing a heart valve on a heart prosthesis and heart prosthesis provided with such a fixing system. | Active | 17-Jan-2023 | ||
| FR-3144913-A1 | System for fixing a heart valve to a cardiac prosthesis and cardiac prosthesis provided with such a fixing system. | Active | 17-Jan-2023 | A61F2/2409 |
Carmat Signals
Carmat Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Carmat FAQs
-
Where is Carmat headquartered?
Carmat is headquartered in Vélizy Villacoublay, France.
-
What is the size of Carmat?
Carmat has 182 total employees.
-
What industry is Carmat in?
Carmat’s primary industry is Therapeutic Devices.
-
Is Carmat a private or public company?
Carmat is a Private company.
-
What is Carmat’s current revenue?
The current revenue for Carmat is .
-
How much funding has Carmat raised over time?
Carmat has raised $532M.
-
Who are Carmat’s investors?
Air Liquide Venture Capital has invested in Carmat.
-
Who are Carmat’s competitors?
SynCardia Systems, Valcare Medical, JenaValve Technology, BrioHealth Solutions, and enVVeno Medical are some of the 12 competitors of Carmat.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process